Intracerebral hemorrhage: Getting ready for effective treatments

Current Opinion in Neurology

Volumn 23, Issue 1, 2010, Pages 59-64

  Rincon, Fred ^a   Mayer, Stephan A ^b  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^b Columbia University ^*  (United States)

Author keywords

Cerebral edema; Hypertension; Intracerebral hemorrhage; Intracranial pressure; Neurological intensive care

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ARGATROBAN; DESMOPRESSIN; DISUFENTON SODIUM; ESMOLOL; FRESH FROZEN PLASMA; HEPARIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; NICARDIPINE; PROTAMINE SULFATE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UROKINASE; VASOACTIVE AGENT; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BLEEDING; BLOOD CLOT LYSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL OCCLUSION; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN EDEMA; BRAIN FUNCTION; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTINUOUS INFUSION; CRANIECTOMY; CRANIOTOMY; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG FATALITY; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERTENSION; INTRACRANIAL HYPERTENSION; MINIMALLY INVASIVE PROCEDURE; MINIMALLY INVASIVE SURGERY; MORTALITY; NONHUMAN; OPTIMAL DRUG DOSE; REVIEW; SINGLE DRUG DOSE; STROKE; THROMBOCYTE TRANSFUSION; UNSPECIFIED SIDE EFFECT;

ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; CRANIOTOMY; DISABILITY EVALUATION; HUMANS; INTRACRANIAL HEMORRHAGE, HYPERTENSIVE;

EID: 74049104555     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283352c01     Document Type: Review

References (67)

1. Sacco RL, Mayer SA. Epidemiology of intracerebral hemorrhage. In: Feld-mann E, editor. Intracerebral hemorrhage. Armonk, NY: Futura Publishing Co; 1994. pp. 3-23.
2. Woo D, Broderick JP. Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. Neurosurg Clin N Am 2002; 13:265-279.
3. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: aguidelinefrom the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38:2001-2023.
4. Mayer SA, Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol 2005; 4:662-672.
5. Morgan T, Awad I, Keyl P, et al. Preliminary report of the Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl 2008; 105:217-220.
6. Minimally Invasive Surgery Olus rtPA for Intracerebral Hemorrhage Evacuation (MISTIE). 2006 [August 9, 2006]; Available from: http://www.stroke- center.org/trials/TrialDetail.aspx?tid=690.
7. Rincon F, Mayer SA. Novel therapies for intracerebral hemorrhage. Curr Opin Crit Care 2004; 10:94-100.
8. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001; 29:635-640.
9. Mirski MA, Chang CW, Cowan R. Impact of aneuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthe-siol 2001; 13:83-92.
10. Hemphill JC 3rd, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 2004; 35:1130-1134.
11. Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 2001; 56:766-772.
12. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncoma-tose patients with supratentorial intracerebral hemorrhage. Neurology 1994; 44:1379-1384.
13. Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 1998; 51:447-451.
14. Mayer SA, Chong J. Critical care management of increased intracranial pressure. J Intensive Care Med 2002; 17:55-67.
15. Kazui S, Minematsu K, Yamamoto H, et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997; 28:2370-2375.
16. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 2007; 38:1072-1075.
17. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28:1-5.
18. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 h) intracerebral hemorrhage. Neurology 2001; 57:18-24.
19. Powers WJ, Adams RE, Yundt KD. Acute pharmacological hypotension after intracerebral hemorrhage does not change cerebral blood flow [abstract]. Stroke 1999; 30:242.
20. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med 1999; 27:965-971.
21. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) trial. International Stroke Conference; February 20-22, 2008; New Orleans, LA. 2008.
22. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7:391-399.
23. Kuwata N, Kuroda K, Funayama M, et al. Dysautoregulation in patients with hypertensive intracerebral hemorrhage. A SPECT study. Neurosurg Rev 1995; 18:237-245.
24. Mayer SA, Lignelli A, Fink ME, et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke 1998; 29:1791-1798.
25. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344:1450-1460.
26. Fujii Y, Takeuchi S, Sasaki O, et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998; 29:1160-1166.
27. Fujii Y, Tanaka R, Takeuchi S, et al. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 1994; 80:51-57. (Pubitemid 24020705)
28. Kazui S, Naritomi H, Yamamoto H, et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996; 27:1783-1787.
29. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352:777-785.
30. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358:2127-2137.
31. Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke 2009; 40:833-840.
32. Wintzen AR, de Jonge H, Loeliger EA, Bots GT. The risk of intracerebral hemorrhage during oral anticoagulant therapy: a population study. Ann Neurol 1984; 16:553-558.
33. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995; 26:1471-1477.
34. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992; 23:972-977.
35. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77:477-480.
36. Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res 2002; 108:25-30.
37. Heit JA. Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001; 12:81-87.
38. Sorensen B, Johansen P, Nielsen GL, et al. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003; 14:469-477.
39. Erhardtsen E, Nony P, Dechavanne M, et al. The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis 1998; 9:741-748.
40. Freeman WD, Brott TG, Barrett KM, et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004; 79:1495-1500.
41. Ananthasubramaniam K, Beattie JN, Rosman HS, et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 2001; 119: 478-484.
42. Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol 1998; 103:1064-1066.
43. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 2000; 57:1710-1713.
44. Wakefield TW, Stanley JC. Intraoperative heparin anticoagulation and its reversal. Semin Vasc Surg 1996; 9:296-302.
45. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308:8-12.
46. Sansing LH, Messe SR, Cucchiara BL, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 2009; 72:1397-1402.
47. Moussouttas M, Malhotra R, Fernandez L, et al. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. Neurocritical care 2009 [Epub ahead of print].
48. Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr, et al. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemor-rhage. J Stroke Cerebrovasc Dis 2009; 18:221-228.
49. Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracer ebral hemorrhage. Stroke 2009; 40:2398-2401.
50. Naval NS, Abdelhak TA, Zeballos P, et al. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocritical care 2008; 8:6-12.
51. Naval NS, Abdelhak TA, Urrunaga N, et al. An association of prior statin use with decreased perihematomal edema. Neurocritical care 2008; 8:13-18.
52. Leker RR, Khoury ST, Rafaeli G, et al. Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009; 40: 2581-2584.
53. Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG, et al. Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study. Cen Eur Neurosurg 2009; 70:15-20.
54. Juvela S, Heiskanen O, Poranen A, et al. The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989; 70:755-758.
55. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 1999; 30: 1833-1839.
56. Fernandes HM, Gregson B, Siddique S, Mendelow AD. Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 2000; 31:2511-2516. (Pubitemid 30740566)
57. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365:387-397.
58. Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl 2006; 96:65-68.
59. Ott KH, Kase CS, Ojemann RG, Mohr JP. Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol 1974; 31:160-167.
60. Murthy JM, Chowdary GV, Murthy TV, et al. Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage. Neurocritical care 2005; 2:258-262.
61. Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 1989; 70:530-535.
62. Wang WZ, Jiang B, Liu HM, et al. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke 2009; 4:11-16.
63. Teernstra OP, Evers SM, Lodder J, et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 2003; 34:968-974.
64. Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32:891-897.
65. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-Day survival. Stroke 2000; 31:841-847.
66. Coplin WM, Vinas FC, Agris JM, et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998; 29:1573-1579.
67. Lapointe M, Haines S. Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev. 2002:CD003692.